Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity
2021 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-021-92734-7
E
Emma Meyer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
40
Citations
4
h-index
0
i10-index
Emma Meyer is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Computational Drug Discovery Methods & COVID-19 Clinical Research Studies & Atrial Fibrillation Management and Outcomes. The author has an h-index of 4, co-authored 15 publications.
ORCID: 0000-0003-1092-0380Papers by this author
worksAvailability of Didactic and Experiential Learning Opportunities in Veterinary Practice at US Pharmacy Programs
2021 · American Journal of Pharmaceutical Education · 5 citations
https://doi.org/10.5688/ajpe8681
A high-throughput assay platform to discover small molecule activators of the phospholipase PLC-γ2 to treat Alzheimer's disease
2025 · Journal of Biological Chemistry · 3 citations
https://doi.org/10.1016/j.jbc.2025.108356
A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19
2023 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2023.e13763
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat